An in vitro investigation into the impact of corneal rinsing on riboflavin/UVA corneal cross-linking

Siân R. Morgan,David P. S. O’Brart,Jinhai Huang,Keith M. Meek,Sally Hayes,David P. S. O'Brart,Keith M. Meek and Sally Hayes
DOI: https://doi.org/10.1186/s40662-024-00375-4
2024-02-29
Eye and Vision
Abstract:Corneal cross-linking (CXL) using riboflavin and ultraviolet-A light (UVA) is a treatment used to prevent progression of keratoconus. This ex vivo study assesses the impact on CXL effectiveness, as measured by tissue enzymatic resistance and confocal microscopy, of including a pre-UVA corneal surface rinse with balanced salt solution (BSS) as part of the epithelium-off treatment protocol.
ophthalmology
What problem does this paper attempt to address?
The problem that this paper attempts to solve is to evaluate whether rinsing the corneal surface with balanced salt solution (BSS) during corneal cross - linking (CXL) treatment will affect the treatment effect. Specifically, the researchers examined the effects of different volumes of BSS rinsing on the efficacy of corneal cross - linking treatment through experiments, especially the changes in corneal enzyme resistance and the concentration of riboflavin in the corneal stroma. This study aims to explore whether the corneal surface should be avoided or restricted from being rinsed with BSS in clinical practice to ensure the optimal efficacy of CXL. ### Research Background Corneal cross - linking treatment is a method used to prevent the progression of keratoconus by using riboflavin and ultraviolet A light (UVA) to enhance the stability of the cornea. However, in actual operation, some ophthalmologists will rinse the corneal surface with BSS before UVA irradiation to remove the riboflavin film on the surface, reduce its possible shielding effect, and optimize the absorption of UVA by the stroma. However, the effectiveness and safety of this practice have not been fully verified. ### Research Objectives The main objective of this study is to evaluate whether rinsing the corneal surface with different volumes of BSS during CXL treatment will reduce the treatment effect. Specific objectives include: 1. **Evaluating the effects of different volumes of BSS rinsing on corneal enzyme resistance**: Evaluate the efficacy of CXL by measuring the resistance of the cornea to collagenase digestion. 2. **Evaluating the effects of different volumes of BSS rinsing on the concentration of riboflavin in the corneal stroma**: Observe the distribution of riboflavin by fluorescence confocal microscopy. ### Research Methods The researchers used 68 porcine eyes for the experiment and divided them into six groups: - **Control group**: Untreated de - epithelialized cornea. - **Riboflavin group**: Only riboflavin/HPMC solution was applied without UVA irradiation. - **CXL group**: After applying riboflavin/HPMC solution, UVA irradiation was carried out without BSS rinsing. - **CXL + 0.25 mL BSS rinsing group**: After applying riboflavin/HPMC solution, rinse with 0.25 mL BSS and then carry out UVA irradiation. - **CXL + 1 mL BSS rinsing group**: After applying riboflavin/HPMC solution, rinse with 1 mL BSS and then carry out UVA irradiation. - **CXL + 10 mL BSS rinsing group**: After applying riboflavin/HPMC solution, rinse with 10 mL BSS and then carry out UVA irradiation. ### Main Results - **Corneal thickness change**: After applying riboflavin/HPMC solution, the central corneal thickness increased significantly (about 9%), but the corneal thickness after UVA irradiation was similar to that of the untreated group. - **Enzyme resistance**: The resistance of all CXL - treated corneas to collagenase was significantly higher than that of the untreated group. However, the enzyme resistance of the 10 mL BSS rinsing group was significantly lower than that of other CXL groups. - **Riboflavin distribution**: The results of fluorescence confocal microscopy showed that the stromal riboflavin fluorescence intensity of the 10 mL BSS rinsing group was significantly lower than that of other groups. ### Conclusion The research results show that rinsing the corneal surface with 10 mL BSS will significantly reduce the efficacy of CXL, mainly because a large amount of rinsing leads to a decrease in the concentration of riboflavin in the stroma. Therefore, it is recommended to avoid using a large amount of BSS for rinsing during CXL treatment. If rinsing is required, using 1 mL or less of BSS has less impact on the efficacy of CXL. Further research is needed in the future to optimize the CXL treatment plan.